Visceral leishmaniasis, which is commonly known as Kala-azar in India, is fatal in over 95% of the cases, if left untreated.
The post New biomolecules to fight drug resistance in Kala-azar appeared first on BioTech Times.
About the Author: Biotech Today
You might like
Blood Cells: The Future of Drug Delivery
5 days ago
3 Likes
19
Basel: It Takes an Ecosystem to Build a Startup
6 days ago
6 Likes
24
The Top European Biotech Funding Rounds in August
2 weeks ago
5 Likes
25